Inhibition of HLA-G Expression Via RNAi Abolishes Resistance of Extravillous Trophoblast Cell Line TEV-1 to NK Lysis

Placenta

Volumn 31, Issue 6, 2010, Pages 519-527

  Chen, L J ^a   Han, Z Q ^a   Zhou, H ^a   Zou, L ^a   Zou, P ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Extravillous trophoblast; HLA G; Immunosuppression; Natural killer cell; Pregnancy; RNA interference

Indexed keywords

CELL ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; PROTEIN ILT2; PROTEIN ILT4; PROTEIN KIR2DL4; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CELL STRAIN NK 92; CELL STRAIN TEV 1; CONFOCAL MICROSCOPY; CORRELATION ANALYSIS; CYTOLYSIS; CYTOTOXICITY; DOWN REGULATION; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA VECTOR; TROPHOBLAST; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFECTION; TROPHOBLASTS;

EID: 77952542134     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.03.008     Document Type: Article

References (50)

1. Trowsdale J., and Betz A.G. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 7 3 (2006) 241-246
2. Adams K.M., Yan Z., Stevens A.M., and Nelson J.L. The changing maternal "self" hypothesis: a mechanism for maternal tolerance of the fetus. Placenta 28 5-6 (2007) 378-382
3. Chen L.J., Zhou H., and Zou L. Defect in lipid rafts results in failed tolerance induction at the maternal-fetal interface: a possible cause for the recurrent spontaneous abortion. Med Hypotheses 71 2 (2008) 275-278
4. Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12 9 (2006) 1065-1074
5. Hatta K., van den Heuvel M.J., and Croy B.A. NK cells detect changes in adaptive immunity within mouse decidua from gestation day eight. Placenta 30 6 (2009) 501-506
6. Parham P. NK cells and trophoblasts: partners in pregnancy. J Exp Med 200 8 (2004) 951-955
7. Scifres C.M., and Nelson D.M. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 587 Pt 14 (2009) 3453-3458
8. Le Gal F.A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11 8 (1999) 1351-1356
9. Munz C., Holmes N., King A., Loke Y.W., Colonna M., Schild H., et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 185 3 (1997) 385-391
10. Bainbridge D.R., Ellis S.A., and Sargent I.L. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 48 1 (2000) 17-26
11. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164 12 (2000) 6100-6104
12. Ristich V., Liang S., Zhang W., Wu J., and Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 35 4 (2005) 1133-1142
13. McIntire R.H., Sifers T., Platt J.S., Ganacias K.G., Langat D.K., and Hunt J.S. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords. Placenta 29 7 (2008) 631-638
14. Ishitani A., and Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 89 9 (1992) 3947-3951
15. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 94 21 (1997) 11520-11525
16. Wang S.S., Han J.Y., Wu X.W., Cao R.H., Qi H.G., Xia Z.X., et al. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity. Transplant Proc 36 8 (2004) 2473-2474
17. Pazmany L., Mandelboim O., Vales-Gomez M., Davis D.M., Reyburn H.T., and Strominger J.L. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274 5288 (1996) 792-795
18. Lee N., Goodlett D.R., Ishitani A., Marquardt H., and Geraghty D.E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 160 10 (1998) 4951-4960
19. Bainbridge D., Ellis S., Le Bouteiller P., and Sargent I. HLA-G remains a mystery. Trends Immunol 22 10 (2001) 548-552
20. Sun L.L., Han Y., Chen J.H., and Yao Y.Q. Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro. Fertil Steril 90 6 (2008) 2398-2405
21. Palmisano G.L., Contardi E., Morabito A., Gargaglione V., Ferrara G.B., and Pistillo M.P. HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines. Hum Immunol 66 1 (2005) 1-12
22. Feng H.C., Choy M.Y., Deng W., Wong H.L., Lau W.M., Cheung A.N., et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig 12 4 (2005) e21-e32
23. Desai S.A., Wang X., Noronha E.J., Zhou Q., Rebmann V., Grosse-Wilde H., et al. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains. J Immunol 165 6 (2000) 3275-3283
24. Pejcic-Karapetrovic B., Gurnani K., Russell M.S., Finlay B.B., Sad S., and Krishnan L. Pregnancy impairs the innate immune resistance to Salmonella typhimurium leading to rapid fatal infection. J Immunol 179 9 (2007) 6088-6096
25. Krishnan L., Pejcic-Karapetrovic B., Gurnani K., Zafer A., and Sad S. Pregnancy does not deter the development of a potent maternal protective CD8+ T-cell acquired immune response against Listeria monocytogenes despite preferential placental colonization. Am J Reprod Immunol 63 1 (2010) 54-65
26. Le Bouteiller P. HLA-G in the human placenta: expression and potential functions. Biochem Soc Trans 28 2 (2000) 208-212
27. Sargent I.L. Does 'soluble' HLA-G really exist? Another twist to the tale. Mol Hum Reprod 11 10 (2005) 695-698
28. Yao Y.Q., Barlow D.H., and Sargent I.L. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol 175 12 (2005) 8379-8385
29. Hunt J.S., Petroff M.G., McIntire R.H., and Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 19 7 (2005) 681-693
30. James J.L., and Chamley L.W. A caution on the use of HLA-G isoforms as markers of extravillous trophoblasts. Placenta 29 3 (2008) 305-306
31. King A., Burrows T.D., Hiby S.E., Bowen J.M., Joseph S., Verma S., et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 21 4 (2000) 376-387
32. Braud V., Jones E.Y., and McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 27 5 (1997) 1164-1169
33. Riteau B., Menier C., Khalil-Daher I., Martinozzi S., Pla M., Dausset J., et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 13 2 (2001) 193-201
34. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., and Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111 10 (2008) 4862-4870
35. Khalil-Daher I., Riteau B., Menier C., Sedlik C., Paul P., Dausset J., et al. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol 43 2 (1999) 175-182
36. Lo Monaco E., Sibilio L., Melucci E., Tremante E., Suchanek M., Horejsi V., et al. HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides. J Immunol 181 8 (2008) 5442-5450
37. Harun R., Ruban L., Matin M., Draper J., Jenkins N.M., Liew G.C., et al. Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation events. Hum Reprod 21 6 (2006) 1349-1358
38. Apps R., Murphy S.P., Fernando R., Gardner L., Ahad T., and Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127 1 (2009) 26-39
39. Zhong M., Weng X., Liang Z., Lu S., Li J., Chen X., et al. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse. Transplantation 87 1 (2009) 8-15
40. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2 9 (2002) 656-663
41. Lopez-Botet M., Llano M., Navarro F., and Bellon T. NK cell recognition of non-classical HLA class I molecules. Semin Immunol 12 2 (2000) 109-119
42. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 100 15 (2003) 8856-8861
43. Dambaeva S.V., Bondarenko G.I., Grendell R.L., Kravitz R.H., Durning M., and Golos T.G. Non-classical MHC-E (Mamu-E) expression in the rhesus monkey placenta. Placenta 29 1 (2008) 58-70
44. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 95 9 (1998) 5199-5204
45. King A., Allan D.S., Bowen M., Powis S.J., Joseph S., Verma S., et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 30 6 (2000) 1623-1631
46. Apps R., Gardner L., Hiby S.E., Sharkey A.M., and Moffett A. Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells. Immunology 124 3 (2008) 322-328
47. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200 8 (2004) 957-965
48. LeMaoult J., Zafaranloo K., Le Danff C., and Carosella E.D. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19 6 (2005) 662-664
49. Favier B., Lemaoult J., Lesport E., and Carosella E.D. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J (2009) 10.1096/fj.09-135194 [Epub ahead of print]
50. Lash G.E., Robson S.C., and Bulmer J.N. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta 31 S (2010) S87-S92